Literature DB >> 8960600

Intermediate-term outcome of transcatheter secundum atrial septal defect closure using the Bard Clamshell Septal Umbrella.

L R Prieto1, C K Foreman, J P Cheatham, L A Latson.   

Abstract

Of 31 patients who underwent transcatheter atrial septal defect occlusion with the Bard Clamshell Septal Umbrella, only 1 had a clinically significant residual atrial septal defect at a mean follow-up of 41 months. All patients were asymptomatic despite the occurrence of device arm fractures in 84% of these patients.

Entities:  

Mesh：

Year:  1996        PMID： 8960600     DOI： 10.1016/s0002-9149(96)00620-0

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


  8 in total

Review 1.  Atrial septum defect closure device in a beating heart, from the perspective of a researcher in artificial organs.

Authors:  Yasuko Tomizawa
Journal:  J Artif Organs       Date:  2012-06-23       Impact factor: 1.731

2.  Ceraflex versus Amplatzer occluder for secundum atrial septal defect closure. Multicenter clinical experience.

Authors:  M A Astarcioglu; M Kalcik; T Sen; A C Aykan; T Gokdeniz; O M Gursoy; S Karakoyun; S Kulahcioglu; S Gunduz; C Kilit; M Oylumlu; B Amasyali
Journal:  Herz       Date:  2015-02-08       Impact factor: 1.443

Review 3.  [Interventions in congenital heart disease and their sequelae in adults].

Authors:  A A Schmaltz; U Neudorf; S Sack; O Galal
Journal:  Herz       Date:  1999-06       Impact factor: 1.443

4.  Transcatheter closure of atrial septal defects using the Cardio-Seal implant.

Authors:  C A Pedra; J Pihkala; K J Lee; C Boutin; D G Nykanen; P R McLaughlin; D A Harrison; R M Freedom; L Benson
Journal:  Heart       Date:  2000-09       Impact factor: 5.994

5.  Surgical and transcatheter (Amplatzer) closure of atrial septal defects: a prospective comparison of results and cost.

Authors:  J D R Thomson; E H Aburawi; K G Watterson; C Van Doorn; J L Gibbs
Journal:  Heart       Date:  2002-05       Impact factor: 5.994

6.  Biocompatibility of septal defect closure devices.

Authors:  Matthias Sigler; Christian Jux
Journal:  Heart       Date:  2006-10-11       Impact factor: 5.994

7.  Early ECG abnormalities associated with transcatheter closure of atrial septal defects using the Amplatzer septal occluder.

Authors:  S L Hill; C I Berul; H T Patel; J Rhodes; S E Supran; Q L Cao; Z M Hijazi
Journal:  J Interv Card Electrophysiol       Date:  2000-10       Impact factor: 1.900

8.  Cribriform amplatzer device closure of fenestrated atrial septal defects: feasibility and technical aspects.

Authors:  Mohammed Numan; Amal El Sisi; Magdi Tofeig; Salwa Gendi; Tohami Tohami; Howaida G El-Said
Journal:  Pediatr Cardiol       Date:  2007-11-13       Impact factor: 1.655
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.